Has Helen Torok, MD received payments from drug or device companies?

Yes. Drug and device makers reported $37,761 in general payments to Helen Torok, MD across 1,679 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Helen Torok, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Helen Torok, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Helen Torok, MD

Dermatology · Medina, OHNPI 1235198698

Payments from drug & device makers

$37,761in general payments, 2019–2025

Across 1,679 payments — averaging $22.49 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

AbbVie$6K
E.r. Squibb & Sons, L.L.C.$5K
Galderma Laboratories, L.p.$3K
Amgen$3K
Sun Pharmaceutical Industries Inc.$2K
Novartis$2K
plus $16K from 34 others

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
AbbVie(2 entities)	338	$5,825
E.r. Squibb & Sons, L.L.C.	61	$5,445
Galderma Laboratories, L.p.	113	$2,713
Amgen	134	$2,632
Sun Pharmaceutical Industries Inc.	145	$2,456
Novartis	131	$2,362
Regeneron Healthcare Solutions, Inc.	104	$1,858
Arcutis Biotherapeutics, Inc.	28	$1,856
UCB, Inc.	76	$1,725
Incyte Corporation	32	$1,461
Johnson & Johnson	92	$1,354
Sanofi	45	$1,120
Lilly USA, LLC	51	$1,010
Dermavant Sciences, Inc.	67	$895
LEO Pharma Inc.	43	$868
EPI Health, LLC	36	$704
Ortho Dermatologics, A Division Of Bausch Health US, LLC	37	$521
VYNE Pharmaceuticals Inc.	26	$513
Pfizer	22	$450
Bristol Myers Squibb	30	$439
Janssen Scientific Affairs, LLC	4	$347
Dermira, Inc.	13	$246
Boehringer Ingelheim	8	$220
Organon	9	$140
Mayne Pharma Commercial LLC	6	$108
Stemline Therapeutics Inc.	2	$90
Almirall LLC	6	$85
Strata Skin Sciences, Inc.	5	$39
Biofrontera Inc.	2	$33
Cipher Pharmaceuticals US LLC	1	$33
Prugen, Inc. Pharmaceuticals	2	$29
Taro Pharmaceuticals USA, Inc.	2	$26
Merck	1	$25
Revance Therapeutics, Inc.	1	$21
Organogenesis Inc.	1	$21
Sandoz	1	$20
Verrica Pharmaceuticals Inc.	1	$19
Aclaris Therapeutics, Inc.	1	$19
DUSA Pharmaceuticals, Inc.	1	$15
Fresenius Kabi USA, LLC	1	$14

How this compares

$37,761 in reported general payments places this provider in the 85th percentile of 460 dermatology providers in Ohio.

See all dermatology providers in Ohio →

Medicare billing

Part B allowed, 2024

$438,591

Medicare patients

1,480

Services billed

6,136

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other dermatology in Medina

Matthew ReedyMedina$61K
Matthew ZirwasBexley$7.4M
Neil KormanCleveland$6M
Jeffrey TraversDayton$4.7M
Jennifer NashWesterville$4M
Jessica KaffenbergerColumbus$3.2M
Rocco SerraoDayton$3M
Patrick ShannonBoardman$2M
George DrewMarion$2M
Benjamin BoguckiColumbus$2M

See the full list for Ohio →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →